Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses

Area of Science:

• Immunology
• Materials Science
• Biotechnology

Background:

• Dendritic cells (DCs) are crucial for T cell activation and are key targets for cancer immunotherapy.
• Artificial antigen-presenting cells (aAPCs) aim to replicate DC functions for enhanced anti-tumor responses.
• Current aAPC strategies face challenges in mimicking the complexity of natural DC interactions.

Purpose of the Study:

• To design and characterize a novel synthetic dendritic cell (sDC) that effectively mimics natural DCs.
• To evaluate the T cell activation capabilities of bifunctional sDCs carrying anti-CD3 and anti-CD28 antibodies.
• To compare the efficacy of sDCs with soluble antibodies and monofunctional sDCs.

Main Methods:

• Development of a semiflexible poly(isocyano peptide) polymer backbone for sDC construction.
• Immobilization of anti-CD3 and anti-CD28 antibodies onto the polymer to create bifunctional sDCs.
• Assessment of T cell activation thresholds and specificity using flow cytometry and functional assays.

Main Results:

• Bifunctional αCD3/αCD28-sDCs trigger T cell activation at significantly lower antibody concentrations than soluble antibodies.
• sDCs demonstrate superior performance compared to a mixture of monofunctional sDCs.
• The co-localization of antibodies on sDCs enhances T cell activation and shapes the specificity of the T cell response, promoting multifunctional killer cells.

Conclusions:

• Multifunctional polymers can effectively mimic natural dendritic cells.
• The developed sDCs show significant potential for enhancing T cell activation in cancer immunotherapy.
• This approach offers a promising strategy for developing next-generation immunotherapeutics.